Annotation Detail for CCDC69

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CCDC69 mRNA | decreases expression | 19933214
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CCDC69 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of CCDC69 mRNA | decreases expression | 18042831
|
C041786 |
palm oil |
palm oil results in decreased expression of CCDC69 mRNA | decreases expression | 18042831
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of CCDC69 mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.37 | 15238619 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.25 | 20435547 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.36 | 15131321 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.70 | 18367378 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.00 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
9.00 | 19551842 17967931 18296743 19004024 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.35 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
10.35 | 18296743 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.97 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
4.02 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.59 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
8.21 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
8.21 | 14714311 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.05 | 18296743 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 18481113 19348381 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.35 | 21332399 20518802 18674790 20132043 17217161 11836018 18457598 19632207 16723640 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.06 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |
PharmGKB Accession:PA128394640
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |